Amalgamated Bank’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.17M | Sell |
19,699
-1,394
| -7% | -$274K | 0.03% | 519 |
|
|
2026
Q1 | $4.13M | Buy |
21,093
+467
| +2% | +$90.7K | 0.03% | 489 |
|
|
2025
Q4 | $3.58M | Sell |
20,626
-925
| -4% | -$168K | 0.03% | 561 |
|
|
2025
Q3 | $4.11M | Sell |
21,551
-398
| -2% | -$70.6K | 0.03% | 504 |
|
|
2025
Q2 | $3.94M | Buy |
21,949
+325
| +2% | +$56.5K | 0.03% | 492 |
|
|
2025
Q1 | $3.66M | Buy |
21,624
+182
| +0.8% | +$29.9K | 0.03% | 505 |
|
|
2024
Q4 | $3.23M | Sell |
21,442
-415
| -2% | -$64.5K | 0.03% | 589 |
|
|
2024
Q3 | $3.39M | Sell |
21,857
-7,147
| -25% | -$1.07M | 0.03% | 572 |
|
|
2024
Q2 | $3.97M | Buy |
29,004
+162
| +0.6% | +$22.2K | 0.03% | 540 |
|
|
2024
Q1 | $3.84M | Buy |
28,842
+552
| +2% | +$71.6K | 0.03% | 589 |
|
|
2023
Q4 | $3.9M | Sell |
28,290
-1,130
| -4% | -$149K | 0.03% | 615 |
|
|
2023
Q3 | $3.58M | Buy |
29,420
+556
| +2% | +$74.1K | 0.03% | 606 |
|
|
2023
Q2 | $4.06M | Sell |
28,864
-1,701
| -6% | -$234K | 0.03% | 546 |
|
|
2023
Q1 | $4.32M | Sell |
30,565
-10,165
| -25% | -$1.45M | 0.04% | 513 |
|
|
2022
Q4 | $6.37M | Buy |
40,730
+8,324
| +26% | +$1.2M | 0.06% | 346 |
|
|
2022
Q3 | $3.98M | Sell |
32,406
-4,060
| -11% | -$535K | 0.04% | 495 |
|
|
2022
Q2 | $4.85M | Buy |
36,466
+3,631
| +11% | +$495K | 0.05% | 431 |
|
|
2022
Q1 | $4.49M | Sell |
32,835
-2,201
| -6% | -$307K | 0.03% | 539 |
|
|
2021
Q4 | $6.06M | Buy |
35,036
+832
| +2% | +$127K | 0.04% | 415 |
|
|
2021
Q3 | $4.97M | Sell |
34,204
-4,028
| -11% | -$589K | 0.04% | 501 |
|
|
2021
Q2 | $5.04M | Buy |
38,232
+30,928
| +423% | +$4.05M | 0.04% | 547 |
|
|
2021
Q1 | $937K | Sell |
7,304
-278
| -4% | -$34.3K | 0.04% | 615 |
|
|
2020
Q4 | $904K | Sell |
7,582
-13
| -0.2% | -$1.58K | 0.03% | 608 |
|
|
2020
Q3 | $870K | Sell |
7,595
-154
| -2% | -$18.2K | 0.04% | 516 |
|
|
2020
Q2 | $883K | Sell |
7,749
-11,748
| -60% | -$1.25M | 0.04% | 478 |
|
|
2020
Q1 | $1.57M | Sell |
19,497
-770
| -4% | -$79.7K | 0.04% | 445 |
|
|
2019
Q4 | $2.16M | Buy |
20,267
+1,366
| +7% | +$142K | 0.04% | 464 |
|
|
2019
Q3 | $2.02M | Sell |
18,901
-380
| -2% | -$39K | 0.04% | 431 |
|
|
2019
Q2 | $1.96M | Buy |
19,281
+2,089
| +12% | +$201K | 0.05% | 410 |
|
|
2019
Q1 | $1.55M | Buy |
17,192
+468
| +3% | +$40.6K | 0.04% | 519 |
|
|
2018
Q4 | $1.39M | Sell |
16,724
-331
| -2% | -$31K | 0.04% | 484 |
|
|
2018
Q3 | $1.84M | Sell |
17,055
-412
| -2% | -$45.2K | 0.05% | 407 |
|
|
2018
Q2 | $1.92M | Buy |
17,467
+462
| +3% | +$48.1K | 0.05% | 408 |
|
|
2018
Q1 | $1.71M | Sell |
17,005
-213
| -1% | -$21.8K | 0.05% | 451 |
|
|
2017
Q4 | $1.7M | Buy |
17,218
+1,529
| +10% | +$145K | 0.05% | 439 |
|
|
2017
Q3 | $1.47M | Buy |
15,689
+272
| +2% | +$28.9K | 0.05% | 438 |
|
|
2017
Q2 | $1.71M | Buy |
15,417
+5,521
| +56% | +$584K | 0.06% | 340 |
|
|
2017
Q1 | $972K | Buy |
9,896
+574
| +6% | +$54.7K | 0.05% | 447 |
|
|
2016
Q4 | $857K | Buy |
9,322
+2,685
| +40% | +$231K | 0.04% | 555 |
|
|
2016
Q3 | $562K | Sell |
6,637
-9
| -0.1% | -$756 | 0.03% | 680 |
|
|
2016
Q2 | $572K | Buy |
6,646
+1,520
| +30% | +$116K | 0.03% | 670 |
|
|
2016
Q1 | $366K | Buy |
5,126
+1,355
| +36% | +$90.9K | 0.04% | 741 |
|
|
2015
Q4 | $268K | Sell |
3,771
-1,227
| -25% | -$82.5K | 0.03% | 860 |
|
|
2015
Q3 | $307K | Buy |
4,998
+141
| +3% | +$9.86K | 0.03% | 866 |
|
|
2015
Q2 | $352K | Buy |
4,857
+256
| +6% | +$18.9K | 0.03% | 837 |
|
|
2015
Q1 | $354K | Buy |
4,601
+1,168
| +34% | +$83.6K | 0.04% | 593 |
|
|
2014
Q4 | $230K | Sell |
3,433
-563
| -14% | -$35.5K | 0.04% | 733 |
|
|
2014
Q3 | $242K | Buy |
3,996
+26
| +0.7% | +$1.6K | 0.04% | 704 |
|
|
2014
Q2 | $233K | Buy |
3,970
+423
| +12% | +$24.8K | 0.04% | 748 |
|
|
2014
Q1 | $205K | Buy |
+3,547
| New | +$190K | 0.04% | 751 |
|
Other funds holding DGX
MGP
AIM
Amalgamated Bank's DGX Position: Q2 2026 in Review
Amalgamated Bank reduced its Quest Diagnostics (DGX) stake by 6.6% in Q2 2026, selling an estimated $274K and leaving 19,699 shares worth $4.17M. The position accounts for 0.03% of the portfolio, ranked #519.
Amalgamated Bank first reported a position in DGX in Q1 2014 and has held it in 50 quarters since. The position peaked at $6.37M in Q4 2022. 634 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Amalgamated Bank held 19,699 shares of Quest Diagnostics worth $4.17M as of Q2 2026.
- Amalgamated Bank sold 1,394 Quest Diagnostics shares in Q2 2026, an estimated $274K.
- Quest Diagnostics made up 0.03% of Amalgamated Bank's portfolio in Q2 2026, its #519 holding.
- Amalgamated Bank first reported a position in Quest Diagnostics in Q1 2014 and has held it in 50 quarters since.
- Amalgamated Bank's Quest Diagnostics position peaked at $6.37M in Q4 2022.
- 634 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.